Patents by Inventor Benjamin Pless

Benjamin Pless has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11918806
    Abstract: Systems and methods include a wearable device with an electrically conductive skin interface that excites the underlying nerves from a transcutaneous surface stimulator. The device may be sized for a range of user sizes with stimulation electrodes positioned to target the appropriate nerves, such as the saphenous and/or posterior tibial nerves. The therapy may be adjusted based on leg restlessness or movement.
    Type: Grant
    Filed: May 11, 2022
    Date of Patent: March 5, 2024
    Assignee: Cala Health, Inc.
    Inventors: Serena HanYing Wong, Kathryn H. Rosenbluth, Samuel Richard Hamner, Peter Lin, Benjamin Pless
  • Publication number: 20240001120
    Abstract: Systems and methods are provided for neurostimulation timed relative to respiratory activity. Neurostimulation may be delivered to the spinal cord, the vagus nerve, and/or branches of the vagus nerve to provide therapeutic outcomes by controlling or adjusting stimulation based on pulmonary activity. In particular, the systems and methods use a detecting device to detect respiratory activity over time. Specific points in the respiratory signal are identified where central autonomic nuclei may be more receptive to afferent input and a stimulator is instructed to provide neurostimulation to at least one auricular branch of a vagus nerve, or to a cervical branch of the vagus nerve, or to a spinal cord of the subject. In this regard, the neurostimulation is advantageously correlated to the detected respiratory activity providing improved therapeutic outcomes.
    Type: Application
    Filed: September 18, 2023
    Publication date: January 4, 2024
    Inventors: Vitaly Napadow, Jill M. Goldstein, Ronald G. Garcia, Benjamin Pless
  • Patent number: 11794012
    Abstract: Systems and methods are provided for neurostimulation timed relative to respiratory activity. Neurostimulation may be delivered to the spinal cord, the vagus nerve, and/or branches of the vagus nerve to provide therapeutic outcomes by controlling or adjusting stimulation based on pulmonary activity. In particular, the systems and methods use a detecting device to detect respiratory activity over time. Specific points in the respiratory signal are identified where central autonomic nuclei may be more receptive to afferent input and a stimulator is instructed to provide neurostimulation to at least one auricular branch of a vagus nerve, or to a cervical branch of the vagus nerve, or to a spinal cord of the subject. In this regard, the neurostimulation is advantageously correlated to the detected respiratory activity providing improved therapeutic outcomes.
    Type: Grant
    Filed: July 10, 2018
    Date of Patent: October 24, 2023
    Assignee: The General Hospital Corporation
    Inventors: Vitaly Napadow, Jill M. Goldstein, Ronald G. Garcia, Benjamin Pless
  • Publication number: 20230240579
    Abstract: In accordance with some non-limiting examples of the disclosed subject matter, an ingestible system configured to acquire physiological information from an interior of a subject is provided, comprising a substrate and at least one physiological sensor. The at least one physiological sensor can be coupled to the substrate and configured to capture physiological data from at least one of an internal area or an orientation in a digestive tract of the subject. The system can include a controller coupled to the substrate and configured to receive the physiological data and prepare the physiological data for one of transmission from the subject or analysis of the physiological data. The substrate, including the at least one physiological sensor and the controller coupled thereto can be configured to self-orient within the digestive tract of the subject, during ingestion of the system by the subject.
    Type: Application
    Filed: April 11, 2023
    Publication date: August 3, 2023
    Inventors: Jeremy Ruskin, Benjamin Pless
  • Patent number: 11690550
    Abstract: In accordance with some non-limiting examples of the disclosed subject matter, an ingestible system configured to acquire physiological information from an interior of a subject is provided, comprising a substrate and at least one physiological sensor. The at least one “physiological sensor can be coupled to the substrate and configured to capture physiological data from at least one of an internal area or an orientation in a digestive tract of the subject. The system can include a controller coupled to the substrate and configured to receive the physiological data and prepare the physiological data for one of transmission from the subject or analysis of the physiological data. The substrate, including the at least one physiological sensor and the controller coupled thereto can be configured to self-orient within the digestive tract of the subject, during ingestion of the system by the subject.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: July 4, 2023
    Assignee: The General Hospital Corporation
    Inventors: Jeremy Ruskin, Benjamin Pless
  • Publication number: 20220347473
    Abstract: Methods, devices, and systems induce neuromodulation by focusing a source of stimulation through a skull/brain interface in the form of an aperture formed in the skull, a naturally occurring fenestration in the skull, or a transcranial channel. Methods, devices, and systems identify where to locate skull/brain interfaces, accessories that can be used with the interfaces, and features for controlling stimulation delivered through the interfaces. Multiple indications for the skull/brain interfaces include diagnosis and treatment of neurological disorders and conditions such as epilepsy, movement disorders, depression, Alzheimer's disease, autism, coma, and pain.
    Type: Application
    Filed: June 29, 2022
    Publication date: November 3, 2022
    Inventors: Brett WINGEIER, Daniel CHAO, Benjamin PLESS, Thomas TCHENG
  • Publication number: 20220266011
    Abstract: In some embodiments, systems and methods can include a wearable device with an electrically conductive skin interface that excites the underlying nerves from a transcutaneous surface stimulator. The device may be sized for a range of user sizes with stimulation electrodes positioned to target the appropriate nerves, such as the saphenous and/or posterior tibial nerves. The therapy may be adjusted based on leg restlessness or movement.
    Type: Application
    Filed: May 11, 2022
    Publication date: August 25, 2022
    Inventors: Serena HanYing Wong, Kathryn H. Rosenbluth, Samuel Richard Hamner, Peter Lin, Benjamin Pless
  • Patent number: 11406824
    Abstract: Methods, devices, and systems induce neuromodulation by focusing a source of stimulation through a skull/brain interface in the form of an aperture formed in the skull, a naturally occurring fenestration in the skull, or a transcranial channel. Methods, devices, and systems identify where to locate skull/brain interfaces, accessories that can be used with the interfaces, and features for controlling stimulation delivered through the interfaces. Multiple indications for the skull/brain interfaces include diagnosis and treatment of neurological disorders and conditions such as epilepsy, movement disorders, depression, Alzheimer's disease, autism, coma, and pain.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: August 9, 2022
    Assignee: NeuroPace, Inc.
    Inventors: Brett Wingeier, Daniel Chao, Benjamin Pless, Thomas Tcheng
  • Patent number: 11344722
    Abstract: In some embodiments, systems and methods can include a wearable device with an electrically conductive skin interface that excites the underlying nerves from a transcutaneous surface stimulator. The device may be sized for a range of user sizes with stimulation electrodes positioned to target the appropriate nerves, such as the saphenous and/or posterior tibial nerves. Transcutaneous afferent stimulation of one, two, or more peripheral nerves can modulate a brain or spinal pathway associated with bladder function.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: May 31, 2022
    Assignee: CALA HEALTH, INC.
    Inventors: Serena HanYing Wong, Kathryn H. Rosenbluth, Samuel Richard Hamner, Peter Lin, Benjamin Pless
  • Publication number: 20210205619
    Abstract: In some embodiments, systems and methods can include a wearable device with an electrically conductive skin interface that excites the underlying nerves from a transcutaneous surface stimulator. The device may be sized for a range of user sizes with stimulation electrodes positioned to target the appropriate nerves, such as the saphenous and/or posterior tibial nerves. Transcutaneous afferent stimulation of one, two, or more peripheral nerves can modulate a brain or spinal pathway associated with bladder function.
    Type: Application
    Filed: January 20, 2017
    Publication date: July 8, 2021
    Inventors: Serena HanYing Wong, Kathryn H. Rosenbluth, Samuel Richard Hamner, Peter Lin, Benjamin Pless
  • Publication number: 20200229725
    Abstract: In accordance with some non-limiting examples of the disclosed subject matter, an ingestible system configured to acquire physiological information from an interior of a subject is provided, comprising a substrate and at least one physiological sensor. The at least one “physiological sensor can be coupled to the substrate and configured to capture physiological data from at least one of an internal area or an orientation in a digestive tract of the subject. The system can include a controller coupled to the substrate and configured to receive the physiological data and prepare the physiological data for one of transmission from the subject or analysis of the physiological data. The substrate, including the at least one physiological sensor and the controller coupled thereto can be configured to self-orient within the digestive tract of the subject, during ingestion of the system by the subject.
    Type: Application
    Filed: July 26, 2018
    Publication date: July 23, 2020
    Inventors: Jeremy Ruskin, Benjamin Pless
  • Publication number: 20200139126
    Abstract: Systems and methods are provided for neurostimulation timed relative to respiratory activity. Neurostimulation may be delivered to the spinal cord, the vagus nerve, and/or branches of the vegus nerve to provide therapeutic outcomes by controlling or adjusting stimulation based on pulmonary activity. In particular, the systems and methods use a detecting device to detect respiratory activity over time. Specific points in the respiratory signal are identified where central autonomic nuclei may be more receptive to afferent input and a stimulator is instructed to provide neurostimulation to at least one auricular branch of a vagus nerve, or to a cervical branch of the vagus nerve, or to a spinal cord of the subject. In this regard, the neurostimulation is advantageously correlated to the detected respiratory activity providing improved therapeutic outcomes.
    Type: Application
    Filed: July 10, 2018
    Publication date: May 7, 2020
    Inventors: Vitaly Napadow, Jill M. Goldstein, Ronald G. Garcia, Benjamin Pless
  • Publication number: 20190111258
    Abstract: Methods, devices, and systems induce neuromodulation by focusing a source of stimulation through a skull/brain interface in the form of an aperture formed in the skull, a naturally occurring fenestration in the skull, or a transcranial channel. Methods, devices, and systems identify where to locate skull/brain interfaces, accessories that can be used with the interfaces, and features for controlling stimulation delivered through the interfaces. Multiple indications for the skull/brain interfaces include diagnosis and treatment of neurological disorders and conditions such as epilepsy, movement disorders, depression, Alzheimer's disease, autism, coma, and pain.
    Type: Application
    Filed: December 12, 2018
    Publication date: April 18, 2019
    Inventors: Brett WINGEIER, Daniel CHAO, Benjamin PLESS, Thomas TCHENG
  • Patent number: 10188860
    Abstract: Methods, devices, and systems induce neuromodulation by focusing a source of stimulation through a skull/brain interface in the form of an aperture formed in the skull, a naturally occurring fenestration in the skull, or a transcranial channel. Methods, devices, and systems identify where to locate skull/brain interfaces, accessories that can be used with the interfaces, and features for controlling stimulation delivered through the interfaces. Multiple indications for the skull/brain interfaces include diagnosis and treatment of neurological disorders and conditions such as epilepsy, movement disorders, depression, Alzheimer's disease, autism, coma, and pain.
    Type: Grant
    Filed: August 1, 2016
    Date of Patent: January 29, 2019
    Assignee: NeuroPace, Inc.
    Inventors: Brett Wingeier, Daniel Chao, Benjamin Pless, Thomas Tcheng
  • Patent number: 9607195
    Abstract: The patient identification system of the preferred embodiments includes a transponder that is affixed to a patient and functions to communicate information that identifies the patient to a device or series of devices. The series of devices includes at least a first device that collects data from the patient and communicates with the transponder. The patient identification system is preferably designed to identify a patient, and more specifically to identify a patient to be associated with the data collected by the device. The patient identification system, however, may be alternatively used in any suitable environment and for any suitable reason.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: March 28, 2017
    Assignee: Autonomic Technologies, Inc.
    Inventor: Benjamin Pless
  • Patent number: 9597494
    Abstract: Systems, methods and devices are disclosed for directing and focusing signals to the brain for neuromodulation and for directing and focusing signals or other energy from the brain for measurement, heat transfer and imaging. An aperture in the skull and/or a channel device implantable in the skull can be used to facilitate direction and focusing. Treatment and diagnosis of multiple neurological conditions may be facilitated with the disclosed systems, methods and devices.
    Type: Grant
    Filed: June 9, 2016
    Date of Patent: March 21, 2017
    Assignee: NeuroPace, Inc.
    Inventors: Brett Wingeier, Benjamin Pless
  • Patent number: 9597493
    Abstract: Systems, methods and devices are disclosed for directing and focusing signals to the brain for neuromodulation and for directing and focusing signals or other energy from the brain for measurement, heat transfer and imaging. An aperture in the skull and/or a channel device implantable in the skull can be used to facilitate direction and focusing. Treatment and diagnosis of multiple neurological conditions may be facilitated with the disclosed systems, methods and devices.
    Type: Grant
    Filed: June 8, 2016
    Date of Patent: March 21, 2017
    Assignee: NeuroPace, Inc.
    Inventors: Brett Wingeier, Benjamin Pless
  • Publication number: 20160339243
    Abstract: Methods, devices, and systems induce neuromodulation by focusing a source of stimulation through a skull/brain interface in the form of an aperture formed in the skull, a naturally occurring fenestration in the skull, or a transcranial channel. Methods, devices, and systems identify where to locate skull/brain interfaces, accessories that can be used with the interfaces, and features for controlling stimulation delivered through the interfaces. Multiple indications for the skull/brain interfaces include diagnosis and treatment of neurological disorders and conditions such as epilepsy, movement disorders, depression, Alzheimer's disease, autism, coma, and pain.
    Type: Application
    Filed: August 1, 2016
    Publication date: November 24, 2016
    Inventors: Brett Wingeier, Daniel Chao, Benjamin Pless, Thomas Tcheng
  • Publication number: 20160296746
    Abstract: Systems, methods and devices are disclosed for directing and focusing signals to the brain for neuromodulation and for directing and focusing signals or other energy from the brain for measurement, heat transfer and imaging. An aperture in the skull and/or a channel device implantable in the skull can be used to facilitate direction and focusing. Treatment and diagnosis of multiple neurological conditions may be facilitated with the disclosed systems, methods and devices.
    Type: Application
    Filed: June 8, 2016
    Publication date: October 13, 2016
    Inventors: Brett WINGEIER, Benjamin PLESS
  • Publication number: 20160287436
    Abstract: Systems, methods and devices are disclosed for directing and focusing signals to the brain for neuromodulation and for directing and focusing signals or other energy from the brain for measurement, heat transfer and imaging. An aperture in the skull and/or a channel device implantable in the skull can be used to facilitate direction and focusing. Treatment and diagnosis of multiple neurological conditions may be facilitated with the disclosed systems, methods and devices.
    Type: Application
    Filed: June 9, 2016
    Publication date: October 6, 2016
    Inventors: Brett WINGEIER, Benjamin PLESS